Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 2 2

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 6258Carcinoma, Renal Cell 1910Urinary Bladder Neoplasms 1669Kidney Neoplasms 929Breast Neoplasms 792Neoplasms 786Carcinoma, Transitional Cell 590Carcinoma, Non-Small-Cell Lung 522Neoplasm Metastasis 510Melanoma 484Ovarian Neoplasms 466Colorectal Neoplasms 451Lung Neoplasms 435Pancreatic Neoplasms 325Testicular Neoplasms 289Stomach Neoplasms 273Sarcoma 265Uterine Cervical Neoplasms 262Non-Muscle Invasive Bladder Neoplasms 262Head and Neck Neoplasms 241Colonic Neoplasms 217Esophageal Neoplasms 202Squamous Cell Carcinoma of Head and Neck 200Wilms Tumor 196Carcinoma, Hepatocellular 195Endometrial Neoplasms 188Recurrence 162Neuroblastoma 148Urologic Neoplasms 147Small Cell Lung Carcinoma 144

Interventions

Androgen Antagonists 2fasudil 1Surgical Procedures, Operative 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Prostate CA × Genitourinary × Clear all
NCT06835725 2026-04-29

ADAPT-25

British Columbia Cancer Agency

Phase 2 Recruiting
100 enrolled
Genitourinary

Prostate CA

NCT06861192 2025-11-18

Clinical Study of Fasudil Hydrochloride and PD1 Inhibitor Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Zhongda Hospital

Phase 2/3 Recruiting
83 enrolled
Genitourinary

Prostate CA

NCT06834321 2025-09-08

Clinical Study on Neoadjuvant Therapy of Homoharringtonine Combined With Androgen Deprivation for Prostate Cancer

Zhongda Hospital

Phase 2 Recruiting
96 enrolled
Genitourinary

Prostate CA

NCT06861166 2025-03-06

Clinical Study of Geranium Wilfordii Combined With Androgen Deprivation in Neoadjuvant Therapy of Prostate Cancer

Zhongda Hospital

Phase 2/3 Not yet recruiting
95 enrolled
Genitourinary

Prostate CA

Data powered by HemOnc (CC BY 4.0) Colophon âš¡